Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
about
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsMutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccinesCD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cellsAbsence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.Immune defense against pneumonic plagueA parenteral DNA vaccine protects against pneumonic plagueYopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infectionYersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaquesLcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Immune responses to plague infection in wild Rattus rattus, in Madagascar: a role in foci persistence?IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8⁺ T cells responding to infection.Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plagueA protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulattaProtection against pneumonic plague following oral immunization with a non-replicating vaccine.Recombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection.Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.Interaction between Yersinia pestis and the host immune systemCurrent challenges in the development of vaccines for pneumonic plague.Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plagueIntranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.Cell-mediated defense against Yersinia pestis infection.Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plagueD27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.Rational considerations about development of live attenuated Yersinia pestis vaccinesLive-attenuated Yersinia pestis vaccines.Prophylaxis and therapy of plague.Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.Immunology of Yersinia pestis Infection.Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.
P2860
Q28384852-8F487686-BC41-4B4A-A5E7-780D02818666Q28678943-15C74240-B93E-4B33-A80C-98B7599695CAQ33500145-AB26BE81-563F-4545-842B-09E8FCFAA1BBQ33557963-F0BA232E-AF71-4394-B010-C852AB9D8DB1Q33584403-00EF8B5E-AFED-446D-9679-E8F835FEFE06Q33816162-6B734CBB-1B85-408C-AFA1-787C18755BEAQ33826059-C8F20F88-9CC7-4ADC-AFA8-111E093A47B1Q34290878-4416439A-8AE7-4D33-81DD-8358F9DEFCEDQ34298699-11652942-2723-4D2C-BA20-192E317613F0Q34311954-701EC2DF-255C-42CD-A22A-28D87FCC4B7FQ34786724-246BE0C4-F69E-4EF6-94CE-1509376015EAQ34819434-14E755C6-3884-46A4-A90F-C869F640B994Q35202406-2253ECF8-09D5-4998-9340-870AA3435202Q35530270-D1E4C177-7BD2-43C5-928B-0A97DE814CD0Q35665414-6D3EC1A0-EF0C-420E-B635-02E63F10C04BQ35739128-5536C5E2-3F44-4511-9C83-34147D9CB7D2Q35886483-951A7A4E-5D2D-48E5-9926-756B99689325Q36099515-A86D2796-421C-4658-BBD8-90D1479E647BQ36373952-C09CD4C6-846F-43FA-8BB9-5B987FB7BB7CQ36539626-8A4C3BC8-F0B6-44FA-B404-4A1E39E4ACCDQ36594020-E4ABC764-E997-465B-8970-DFD373A18C34Q36628038-B23E60F5-BD34-4E9E-B46C-A987C211C550Q36804222-B5A4BAF0-6336-4A6D-89ED-18546E37EDCFQ36876293-A1B84DE6-0912-440F-8C57-7787A2807803Q36898462-C8F5AB2C-B52F-4D4B-BB4C-104102A526D5Q36911486-315AAB4F-CA10-4F8D-8661-DA9F73CBAB59Q36984064-6B218FFB-9919-44E4-8390-BC698DC29843Q37066697-3683F2A3-5C98-4CAD-AAB0-D5CAD852DF0AQ37066749-DCAE6BBE-B8D0-45DB-B0AB-2E9A7EBD8412Q37355852-BDA30AEB-1020-40BC-B0A0-1EEA98139030Q37355871-D472D255-1266-4FEF-A682-CD7DF77C48DEQ37484974-37A01D14-A064-484C-A9EF-D2238444E4F9Q37688618-9256D7CC-6E15-4167-BCF5-A7FBF7AD9496Q38113270-A593A1C7-DF52-4852-BDEB-DECF3D55DE86Q38131537-B7238D64-6619-4FA6-8181-029EF3AF1D9AQ40485593-A30CF9E1-D22E-4431-8FC1-46325A1841C4Q40512106-A04CDF90-2621-4A60-A4CA-92B69DF30E20Q41432452-BF367E27-4197-467B-A83A-978E1D9E30E5Q41879397-74D10AC1-9C42-44FA-8DD0-A4A2E8559582
P2860
Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vaccination with live Yersinia ...... pulmonary Y. pestis infection.
@en
type
label
Vaccination with live Yersinia ...... pulmonary Y. pestis infection.
@en
prefLabel
Vaccination with live Yersinia ...... pulmonary Y. pestis infection.
@en
P2860
P356
P1476
Vaccination with live Yersinia ...... pulmonary Y. pestis infection.
@en
P2093
Alexander V Philipovskiy
Stephen T Smiley
P2860
P304
P356
10.1128/IAI.01529-06
P407
P577
2006-11-21T00:00:00Z